Who owns MINK THERAPEUTICS INC?
- Ticker: INKT
- CUSIP Number: 603693201
Tip: Access positions for across all investors
Analyze quarterly positions in Mink Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Mink Therapeutics stock
Who bought or sold MINK THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 33k | $467k | 40% | Sep 2025 |
|
| Longbow Finance SA | 17k | $233k | 0% | Sep 2025 |
|
| Renaissance Technologies | 15k | $204k | 100% | Sep 2025 |
|
| Geode Capital Management | 13k | $179k | 11% | Sep 2025 |
|
| BlackRock | 6.3k | $88k | -15% | Sep 2025 |
|
| UBS Group | 5.6k | $79k | 1889% | Sep 2025 |
|
| Tower Research Capital | 926.00 | $13k | 100% | Sep 2025 |
|
| Covestor | 131.00 | $2.0k | 0% | Sep 2025 |
|
| Advisor Group Holdings | 124.00 | $1.7k | 3% | Sep 2025 |
|
| Morgan Stanley | 22.00 | $163.000200 | 100% | Jun 2025 |
|
| Northwestern Mutual Wealth Management Company | 19.00 | $266.000000 | 0% | Sep 2025 |
|
| Game Plan Financial Advisors | 16.00 | $224.000000 | 0% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 16.00 | $224.000000 | -38% | Sep 2025 |
|
| Hartland & Co | 14.00 | $196.000000 | 0% | Sep 2025 |
|
| Jpmorgan Chase & Co | 9.00 | $126.000000 | -70% | Sep 2025 |
|
| Key FInancial | 4.00 | $59.000000 | 0% | Sep 2025 |
|
| Jones Financial Companies, L.L | 1.00 | $14.000000 | 0% | Sep 2025 |
|
Who sold out of Mink Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Wells Fargo & Company | Jun 2025 | 849.00 | $6.3k |
| Total Investment Management | Jun 2025 | 500.00 | $3.7k |
| Raymond James Financial | Jun 2025 | 32.00 | $235.427200 |